Clinical Utility of NGS-Based Diagnosis in Primary Ciliary Dyskinesia: Experience from a Brazilian Pediatric Cohort at a Reference Center for Rare Diseases
Genes · 30.06.2026 · 17 (7) · 767
DOI: 10.3390/genes17070767 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes, online erschienen am 30.06.2026. Verfasst von Patrícia F Barreto M Costa und 13 weiteren Autor:innen. Beteiligte Einrichtung: Setor de Pneumologia, Departamento de Pediatria, Instituto Fernandes Figueira (IFF/FIOCRUZ), Serviço de Referência para Doenças Raras, Ministério da …. Hauptthemen laut MEDLINE: High-Throughput Nucleotide Sequencing, Rare Diseases, Ciliary Motility Disorders, Kartagener Syndrome. Die Arbeit nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Programa de Incentivo à Pesquisa (PIP), Instituto Fernandes Figueira/FIOCRUZ/FIOTEC, Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro, Conselho Nacional de Desenvolvimento Científico e Tecnológico.
Abstract (Originalsprache)
Background
Primary ciliary dyskinesia (PCD) is a rare and genetically heterogeneous disorder that remains underdiagnosed in low- and middle-income countries, largely due to limited access to specialized diagnostic tests. Genetic analysis has become an essential component of PCD diagnosis, particularly where functional and ultrastructural evaluations are unavailable.
Methods
We conducted an investigational study including children and adolescents with clinical suspicion of PCD followed at a Brazilian tertiary center. Clinical characterization included detailed phenotyping and calculation of the PICADAR score. Molecular investigation was performed using exome sequencing as a frontline diagnostic approach.
Results
Among 27 individuals evaluated, 10 (37%) received a confirmed molecular diagnosis of PCD. An additional 6 (22%) individuals had inconclusive molecular findings, mainly due to variants of uncertain significance (VUS), and were classified as likely PCD based on combined clinical and molecular evidence. Higher PICADAR scores were more frequently observed among individuals with confirmed or likely molecular diagnosis, with 9 of 10 confirmed cases presenting a score above 5. Beyond PCD-associated findings, exome sequencing also enabled the identification of clinically relevant additional diagnoses, including cystic fibrosis, FGFR3-related hypochondroplasia, and ACMG-reportable secondary finding involving BRCA2. Some unresolved cases may also reflect inherent technical limitations of exome sequencing, including restricted sensitivity for copy-number variants, suboptimal coverage of highly homologous or GC-rich regions, and limited detection of deep intronic and other variants. Additional factors include challenges in variant interpretation and incomplete knowledge of disease-associated genes.
Conclusions
Frontline exome sequencing is a valuable diagnostic tool for PCD, particularly when integrated with robust clinical phenotyping. Clinical scoring systems such as PICADAR may help prioritize individuals for genetic testing and optimize diagnostic yield in resource-limited settings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Setor de Pneumologia, Departamento de Pediatria, Instituto Fernandes Figueira (IFF/FIOCRUZ), Serviço de Referência para Doenças Raras, Ministério da Saúde, Rio de Janeiro 22250-020, RJ, Brazil.
- Laboratório de Biologia Molecular/Medicina Genômica, Centro de Genética Médica, Instituto Fernandes Figueira (IFF/FIOCRUZ), Serviço de Referência para Doenças Raras, Ministério da Saúde, Rio de Janeiro 22250-020, RJ, Br…
- Instituto Nacional de Doenças Raras (InRaras), Hospital das Clínicas de Porto Alegre, Porto Alegre 90035-903, RS, Brazil.
- Unidade de Genética Clínica, Centro de Genética Médica, Instituto Fernandes Figueira (IFF/FIOCRUZ), Serviço de Referência para Doenças Raras, Ministério da Saúde, Rio de Janeiro 22250-020, RJ, Brazil.
- Centro Universitário Arthur Sá Earp Neto/Faculdade de Medicina de Petrópolis (UNIFASE), Petrópolis 25680-120, RJ, Brazil.
ORCID-Profile: Patrícia F Barreto M Costa, Danielle de Freitas F M Fins, Tania Wrobel Folescu, Renata Wrobel Folescu Cohen, Dafne Horovitz
Förderung
- Programa de Incentivo à Pesquisa (PIP), Instituto Fernandes Figueira/FIOCRUZ/FIOTEC
- Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- CNPq/PIBIC
- CAPES
Zitieren
APA
Costa, P. F. B. M., Fins, D. F. F. M., de Oliveira Moraes, I., Folescu, T. W., Cohen, R. W. F., Chaves Rabelo, N., Azevedo Barreto, L., Vieira da Cunha Moreira, J., Barbosa Abdala, B., Naccarato Teixeira Lopes Andrade, M., Llerena, J., Horovitz, D., Gomes, M. E., & Gonzalez, S. (2026). Clinical Utility of NGS-Based Diagnosis in Primary Ciliary Dyskinesia: Experience from a Brazilian Pediatric Cohort at a Reference Center for Rare Diseases. Genes, 17(7), 767. https://doi.org/10.3390/genes17070767
Vancouver
Costa PFBM, Fins DFFM, de Oliveira Moraes I, Folescu TW, Cohen RWF, Chaves Rabelo N, et al. Clinical Utility of NGS-Based Diagnosis in Primary Ciliary Dyskinesia: Experience from a Brazilian Pediatric Cohort at a Reference Center for Rare Diseases. Genes. 2026;17(7):767. doi:10.3390/genes17070767
BibTeX
@article{Costa2026,
author = {Costa, Patrícia F Barreto M and Fins, Danielle de Freitas F M and de Oliveira Moraes, Isabelle and Folescu, Tania Wrobel and Cohen, Renata Wrobel Folescu and Chaves Rabelo, Natana and Azevedo Barreto, Leticia and Vieira da Cunha Moreira, Julia and Barbosa Abdala, Bianca and Naccarato Teixeira Lopes Andrade, Mariana and Llerena, Juan and Horovitz, Dafne and Gomes, Maria Eduarda and Gonzalez, Sayonara},
title = {Clinical Utility of NGS-Based Diagnosis in Primary Ciliary Dyskinesia: Experience from a Brazilian Pediatric Cohort at a Reference Center for Rare Diseases},
journal = {Genes},
year = {2026},
volume = {17},
number = {7},
pages = {767},
doi = {10.3390/genes17070767}
}
EUVIMED